All Stories

  1. Hypertension-Mediated Organ Damages should be Divided into Acute and Chronic
  2. Low-Frequency Magnetic Resonance Imaging Identifies Hand Joint Subclinical Inflammation in Systemic Sclerosis
  3. Is Osteoarthritis Always Associated with Low Bone Mineral Density in Elderly Patients?
  4. A Discrepancy: Calcium Channel Blockers are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure
  5. Beta Blockers can Mask not only Hypoglycemia but also Hypotension
  6. Diabetic Cardiomyopathy: Clinical and Metabolic Approach
  7. Hypertensive emergency is characterized by acute hypertension-mediated organ damage but also a life-threatening status
  8. Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15‐year prospective study
  9. Impending hypertensive emergency is frequently considered in guidelines, but neither defined nor explained
  10. Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies
  11. Predictors of Cardiovascular Events in Hypertensive Patients with High Cardiovascular Risk
  12. How should we treat very high blood pressure until we distinguish between hypertensive emergency and urgency?
  13. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
  14. Dyslipidemia: Contemporary Therapy Options in Terms of Worldwide Guidelines
  15. Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation
  16. Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits
  17. PROGNOSTIC SIGNIFICANCE OF VISIT-TO-VISIT VARIABILITY, MEAN AND MAXIMUM BLOOD PRESSURE IN TREATED HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
  18. Significance of asymptomatic hyperuricemia in patients after coronary events
  19. A Critical Approach of Guideline Therapeutic Recommendations for NAFLD
  20. Predictive value of metabolic syndrome definitions in patients with myocardial infarction with ST segment elevation – are they all the same?
  21. Patient with coronary artery disease and hypertension
  22. QTc dispersion and Cornell duration product can predict 10-year outcomes in hypertensive patients with left ventricular hypertrophy
  23. THE EFFECT OF DEGREE AND TYPE OF LEFT VENTRICULAR HYPERTROPHY ON VENTRICULAR ARRHYTHMIAS IN HYPERTENSION
  24. [OP.7B.07] FIFTEEN-YEAR PROGNOSTIC SIGNIFICANCE OF ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION
  25. [PP.01.19] PREDICTORS OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
  26. [PP.11.34] THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH HYPERTENSION AND ITS IMPACT ON ASYMPTOMATIC CAROTID ATHEROSCLEROSIS
  27. [PP.05.12] SUBCLINICAL ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK – FACTORS CONTRIBUTING TO THE CHANGE OF LEFT VENTRICULAR MASS AND CAROTID INTIMA MEDIA THICKNESS
  28. [PP.18.03] THE IMPACT OF ARTERIAL HYPERTENSION ON MORTALITY IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
  29. [PP.29.11] METABOLIC SYNDROME AS THE PREDICTOR OF NEW CARDIOVASCULAR EVENTS IN PATIENTS WITH MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION
  30. [PP.33.01] EVALUATION OF HYPERTENSIVE PATIENTS
  31. [PP.33.06] SUBCLINICAL ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
  32. [PP.36.06] THE IMPACT OF SERUM URIC ACID ON ASYMPTOMATIC CAROTID ATHEROSCLEROSIS AND RENAL DISEASE IN HYPERTENSIVE PATIENTS
  33. 4B.09
  34. PP.04.19
  35. Motivation and job satisfaction of health workers in a specialized health institution in Serbia
  36. Association of the thickness of carotid intima-media complex and ancle brachial index with coronary disease severity
  37. Impact of depression on sexual dysfunction and HRQoL in CAD patients
  38. Prevalence of arterial hypertension in Serbia
  39. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
  40. Predictive value of noninvasive markers of atherosclerosis for cardiovascular morbidity and mortality in patients with coronary artery disease (4 years follow-up study)
  41. Eleven years of follow-up of patients with hypertensive left ventricular hypertrophy
  42. Health-related quality of life in patients with coronary artery disease after coronary revascularization
  43. Relation between bone density and certain parameters of lipid status in postmenopausal women
  44. Predictive value of non-invasive parameters in patients with left ventricular hypertrophy during a five-year follow-up period
  45. The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis
  46. GENDER SPECIFIC PROGNOSTIC DIFFERENCES IN REGARD TO THE REGRESSION OF HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY (12 YEARS FOLLOW-UP STUDY)
  47. NINE YEARS FOLLOW-UP OF PATIENTS WITH HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY AND PREDICTIVE VALUE OF NON-INVASIVE PARAMETERS
  48. THE INFLUENCE OF METABOLIC SYNDROME ON THE OCCURRENCE AND SEVERITY OF CAROTID ATHEROSCLEROSIS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
  49. Do we reach target lipid levels in diabetic and non-diabetic patients with previous myocardial infarction?
  50. Application of secondary prevention measures in patients with coronary artery disease - Republic Serbia
  51. Guidelines for rehabilitation of patients with coronary disease
  52. EFFECTS OF THE EARLY ONE YEAR TREATMENT IN HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANCE ON CARDIOVASCULAR EVENTS IN THE FUTURE: PP.22.373
  53. METABOLIC SYNDROME AND ATHEROSCLEROSIS OF CAROTID ARTERIES IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY: PP.2.79
  54. PREDICTIVE VALUE OF NON-INVASIVE PARAMETERS DURING EIGHT YEARS FOLLOW-UP OF PATIENTS WITH HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY: PP.22.378
  55. THE AFFECT OF THE REGRESSION OF THE LEFT VENTRICULAR HYPERTROPHY OF THE FUNCTIONAL CAPACITY IN HYPERTENSIVE PATIENTS: PP.35.487
  56. Five years prognosis of patients with arterial hypertension and left ventricular hypertrophy
  57. Effects of balneotherapy on the reactants of acute inflammation phase in Ankylosing spondylitis
  58. Evaluation of myocardial function in the presence of left ventricular hypertrophy in athletes and hypertensive patients
  59. Correlation between 24-hour profile of blood pressure and ventricular arrhythmias and their prognostic significance in patients with arterial hypertension
  60. Prognostic value of QTc interval dispersion changes during exercise testing in hypertensive men
  61. Carotid atherosclerosis associated to metabolic syndrome and ischemic heart disease in hypertensive patients with left ventricular hypertrophy
  62. Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients
  63. 24-HOUR PULSE PRESSURE AT HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
  64. IMPACT OF LEFT VENTRICULAR HYPERTROPHY ON REGIONAL MYOCARDIAL VELOCITIES IN ATHLETES AND HYPERTENSIVES HEART
  65. 717 Quantification of regional myocardial function detects super-silent myocardial ischaemia in diabetic patients
  66. The relationship between ventricular arrhythmias, heart rate variability and ventricular systolic function